Bile acid indices as biomarkers for liver diseases II: The bile acid score survival prognostic model

Figure 3 Kaplan-Meier survival plots for high vs low bile-acids score, non- bile-acids score, and models for end stage liver diseases. ^aP value < 0.05 from the Log rank and Breslow tests. A: The median cutoff value of the bile-acids score (BAS) was used to define high vs low risk of death; B: The median cutoff value of the non-BAS was used to define high vs low risk of death; C: The median cutoff value of the model for end stage liver diseases was used to define high vs low risk of death. BAS: Bile-acids score; MELD: Model for end stage liver diseases.